PL195043B1 - Środek do leczenia depresji i zastosowanie tego środka - Google Patents
Środek do leczenia depresji i zastosowanie tego środkaInfo
- Publication number
- PL195043B1 PL195043B1 PL99345842A PL34584299A PL195043B1 PL 195043 B1 PL195043 B1 PL 195043B1 PL 99345842 A PL99345842 A PL 99345842A PL 34584299 A PL34584299 A PL 34584299A PL 195043 B1 PL195043 B1 PL 195043B1
- Authority
- PL
- Poland
- Prior art keywords
- clbo
- amount
- sertraline
- propylaminobenzothiazole
- tetrahydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19830201A DE19830201A1 (de) | 1998-07-07 | 1998-07-07 | Mittel mit antidepressiver Wirkung |
| PCT/EP1999/004595 WO2000002542A2 (de) | 1998-07-07 | 1999-07-02 | Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL345842A1 PL345842A1 (en) | 2002-01-14 |
| PL195043B1 true PL195043B1 (pl) | 2007-08-31 |
Family
ID=7873155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99345842A PL195043B1 (pl) | 1998-07-07 | 1999-07-02 | Środek do leczenia depresji i zastosowanie tego środka |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6255329B1 (https=) |
| EP (1) | EP1093369B1 (https=) |
| JP (1) | JP2002520273A (https=) |
| KR (1) | KR100557692B1 (https=) |
| CN (1) | CN1230168C (https=) |
| AR (1) | AR019896A1 (https=) |
| AT (1) | ATE228365T1 (https=) |
| AU (1) | AU762128B2 (https=) |
| BG (1) | BG64972B1 (https=) |
| BR (1) | BR9911768A (https=) |
| CA (1) | CA2336833C (https=) |
| CZ (1) | CZ294087B6 (https=) |
| DE (2) | DE19830201A1 (https=) |
| DK (1) | DK1093369T3 (https=) |
| EA (1) | EA003142B1 (https=) |
| EE (1) | EE04296B1 (https=) |
| ES (1) | ES2183583T3 (https=) |
| HU (1) | HUP0103922A3 (https=) |
| ID (1) | ID27776A (https=) |
| IL (1) | IL140603A0 (https=) |
| MY (1) | MY117969A (https=) |
| NO (1) | NO20010064L (https=) |
| NZ (1) | NZ509729A (https=) |
| PL (1) | PL195043B1 (https=) |
| PT (1) | PT1093369E (https=) |
| RS (1) | RS49795B (https=) |
| SK (1) | SK284923B6 (https=) |
| TR (1) | TR200100146T2 (https=) |
| TW (1) | TW592698B (https=) |
| WO (1) | WO2000002542A2 (https=) |
| YU (1) | YU401A (https=) |
| ZA (1) | ZA200100090B (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2301899C (en) * | 1998-07-27 | 2008-11-18 | Boehringer Ingelheim Pharma Kg | Agent with an antidepressant activity |
| US20020165246A1 (en) * | 2001-03-05 | 2002-11-07 | Andrew Holman | Administration of sleep restorative agents |
| DE10138275A1 (de) * | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Verbindungen zur Beseitigung der Anhedonie |
| US20060281797A1 (en) * | 2001-12-11 | 2006-12-14 | University Of Virginia Patent Foundation | Neurorestoration with R(+) Pramipexole |
| ES2432527T3 (es) * | 2001-12-11 | 2013-12-04 | University Of Virginia Patent Foundation | Uso de pramipexol para tratar la esclerosis lateral amiotrófica |
| DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
| DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
| CA2554616A1 (en) * | 2004-01-22 | 2005-08-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist |
| ATE444750T1 (de) * | 2005-08-15 | 2009-10-15 | Univ Virginia | Neurorestauration mit r(+) pramipexol |
| US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
| ATE537826T1 (de) | 2006-05-16 | 2012-01-15 | Knopp Neurosciences Inc | Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung |
| US20080254118A1 (en) * | 2007-04-11 | 2008-10-16 | Hans-Werner Wernersbach | Process for preparing pramipexole dihydrochloride tablets |
| US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
| JP2010521496A (ja) | 2007-03-14 | 2010-06-24 | ノップ ニューロサイエンシーズ、インク． | キラル精製置換ベンゾチアゾールジアミンの合成 |
| US20080254117A1 (en) * | 2007-04-10 | 2008-10-16 | Noel Cotton | Process for preparing pramipexole dihydrochloride tablets |
| US20110190356A1 (en) * | 2008-08-19 | 2011-08-04 | Knopp Neurosciences Inc. | Compositions and Methods of Using (R)- Pramipexole |
| US20100069390A1 (en) | 2008-09-05 | 2010-03-18 | Supernus Pharmaceuticals, Inc. | Method of treatment of attention deficit/hyperactivity disorder (ADHD) |
| US20120115871A1 (en) * | 2009-04-30 | 2012-05-10 | Supemus Pharmaceuticals, Inc | Method of treatment of depression |
| WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
| ES2950875T3 (es) | 2012-02-08 | 2023-10-16 | Supernus Pharmaceuticals Inc | Formulaciones de liberación modificada de viloxazina |
| US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| PL3019167T3 (pl) | 2013-07-12 | 2021-06-14 | Knopp Biosciences Llc | Leczenie podwyższonych poziomów eozynofili i/lub bazofili |
| US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
| DK3033081T3 (da) | 2013-08-13 | 2021-05-31 | Knopp Biosciences Llc | Sammensætninger og fremgangsmåder til behandling af kronisk urticaria |
| EP3038467B1 (en) | 2013-08-13 | 2020-07-29 | Knopp Biosciences LLC | Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders |
| IL312486B2 (en) * | 2017-04-10 | 2025-05-01 | Chase Therapeutics Corp | NK1 antagonist combination and method for treating synucleinopathies |
| CA3104811C (en) * | 2017-06-30 | 2024-05-28 | Chase Therapeutics Corporation | Composition comprising pramipexole and nk1-antagonists for treating depression |
| CN110028464B (zh) * | 2019-04-26 | 2022-11-18 | 浙江海洋大学 | 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| DE3572485D1 (en) * | 1984-12-22 | 1989-09-28 | Thomae Gmbh Dr K | Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs |
| DE3843227A1 (de) * | 1988-12-22 | 1990-07-05 | Boehringer Ingelheim Kg | Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol |
| US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
| DE3937271A1 (de) * | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
| US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| DE4241013A1 (de) * | 1992-12-05 | 1994-06-09 | Boehringer Ingelheim Kg | Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung |
| JP3947582B2 (ja) * | 1995-08-15 | 2007-07-25 | 中外製薬株式会社 | 不安神経症治療剤 |
| EA001485B1 (ru) * | 1996-03-29 | 2001-04-23 | Пфайзер Инк. | Производные бензил(иден)-лактамов, их получение и применение в качестве селективных (ант)агонистов рецепторов 5-htи/или 5-ht |
| AU734872B2 (en) * | 1996-12-02 | 2001-06-21 | Merck Sharp & Dohme Limited | Use of NK-1 receptor antagonists for treating movement disorders |
| WO1999036064A2 (en) * | 1998-01-13 | 1999-07-22 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders |
-
1998
- 1998-07-07 DE DE19830201A patent/DE19830201A1/de not_active Withdrawn
-
1999
- 1999-07-02 KR KR1020017000088A patent/KR100557692B1/ko not_active Expired - Fee Related
- 1999-07-02 CN CNB998083038A patent/CN1230168C/zh not_active Expired - Fee Related
- 1999-07-02 SK SK11-2001A patent/SK284923B6/sk not_active IP Right Cessation
- 1999-07-02 DE DE59903556T patent/DE59903556D1/de not_active Expired - Fee Related
- 1999-07-02 DK DK99934560T patent/DK1093369T3/da active
- 1999-07-02 EE EEP200100014A patent/EE04296B1/xx not_active IP Right Cessation
- 1999-07-02 RS YUP-4/01A patent/RS49795B/sr unknown
- 1999-07-02 AT AT99934560T patent/ATE228365T1/de not_active IP Right Cessation
- 1999-07-02 JP JP2000558802A patent/JP2002520273A/ja active Pending
- 1999-07-02 ES ES99934560T patent/ES2183583T3/es not_active Expired - Lifetime
- 1999-07-02 EA EA200100084A patent/EA003142B1/ru not_active IP Right Cessation
- 1999-07-02 EP EP99934560A patent/EP1093369B1/de not_active Expired - Lifetime
- 1999-07-02 HU HU0103922A patent/HUP0103922A3/hu unknown
- 1999-07-02 ID IDW20010017A patent/ID27776A/id unknown
- 1999-07-02 TR TR2001/00146T patent/TR200100146T2/xx unknown
- 1999-07-02 CA CA002336833A patent/CA2336833C/en not_active Expired - Fee Related
- 1999-07-02 BR BR9911768-1A patent/BR9911768A/pt not_active Application Discontinuation
- 1999-07-02 IL IL14060399A patent/IL140603A0/xx not_active IP Right Cessation
- 1999-07-02 YU YU401A patent/YU401A/sh unknown
- 1999-07-02 WO PCT/EP1999/004595 patent/WO2000002542A2/de not_active Ceased
- 1999-07-02 CZ CZ200177A patent/CZ294087B6/cs not_active IP Right Cessation
- 1999-07-02 PL PL99345842A patent/PL195043B1/pl not_active IP Right Cessation
- 1999-07-02 PT PT99934560T patent/PT1093369E/pt unknown
- 1999-07-02 AU AU50303/99A patent/AU762128B2/en not_active Ceased
- 1999-07-02 NZ NZ509729A patent/NZ509729A/xx unknown
- 1999-07-06 TW TW088111454A patent/TW592698B/zh not_active IP Right Cessation
- 1999-07-06 US US09/348,591 patent/US6255329B1/en not_active Expired - Fee Related
- 1999-07-07 MY MYPI99002869A patent/MY117969A/en unknown
- 1999-07-07 AR ARP990103294A patent/AR019896A1/es unknown
-
2001
- 2001-01-03 BG BG105112A patent/BG64972B1/bg unknown
- 2001-01-04 ZA ZA200100090A patent/ZA200100090B/en unknown
- 2001-01-05 NO NO20010064A patent/NO20010064L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL195043B1 (pl) | Środek do leczenia depresji i zastosowanie tego środka | |
| JP4925074B2 (ja) | ミルタザピンと１種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物 | |
| US6667329B1 (en) | Agents with antidepressant action, containing pramipexol and second antidepressant | |
| US6573292B1 (en) | Methods and compositions for the treatment of chronic lymphocytic leukemia | |
| US9839627B2 (en) | Methods of treating fragile X associated disorders, ADHD, and autism spectrum disorder | |
| EP0813873B1 (en) | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors | |
| NZ510007A (en) | Use of pramipexole in the treatment of restless legs syndrome | |
| JP3598116B2 (ja) | 遅発性ジスキネジアの治療用医薬組成物とその利用 | |
| KR20020084413A (ko) | 피롤 유도체를 포함하는 약학 조성물 | |
| US6335372B1 (en) | Treatment of obsessive compulsive disorder | |
| SK14162002A3 (sk) | Kombinácia obsahujúca paracetamol alebo nesteroidné protizápalové liečivo, použitie mirtazapínu, paracetamolu a pacientský balíček | |
| MXPA00012880A (en) | Agents with an antidepressive effect | |
| HUP0302752A2 (hu) | 2-Amino-1-(4-hidroxi-3-metánszulfonamido-fenil)-etanolt tartalmazó gyógyszerkészítmény és alkalmazása vizeletinkontinencia kezelésére | |
| David | Oxcarbazepine, Top&mate, Zonisamide, and Levetiracetam: Potential Use in Neuropathic Pain | |
| WO2004037238A1 (en) | New uses of deramciclane | |
| HK1006081B (en) | Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20090702 |